Decoding the CHI3L1/IL-13Rα2 signaling nexus in MASH-fibrosis pathogenesis
Science Advances · 12.12.2025 · 11 (50)
DOI: 10.1126/sciadv.adz3223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 12.12.2025. Verfasst von Qianqian Zheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Basic Medicine College, China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Chitinase-3-Like Protein 1, Signal Transduction, Interleukin-13 Receptor alpha2 Subunit, Liver Cirrhosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Liaoning Province, Department of Education of Liaoning Province.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease driven by chronic inflammation and fibrosis, yet the immune mechanisms behind it remain unclear. We identify chitinase 3-like 1 (CHI3L1) as a key mediator linking immune activation to fibrotic remodeling in MASH. Across hepatocyte-macrophage coculture and recombinant interleukin-17A (IL-17A) stimulation assays, we delineate a hepatocyte-associated IL-17A signal that augments macrophage CHI3L1 expression via c-Jun N-terminal kinase (JNK)/c-Jun signaling. CHI3L1 then binds to IL-13Rα2 on hepatic stellate cells (HSCs), triggering a p38 mitogen-activated protein kinase (MAPK)/activating transcription factor 3 (ATF3) cascade that induces lipocalin-2 (LCN2), promoting HSC activation and fibrosis. Using cell-specific knockout models, we show that deleting Chi3l1 in macrophages or Il13ra2 in HSCs markedly reduces liver inflammation and fibrosis. Furthermore, CHI3L1-neutralizing antibodies disrupt this circuit and significantly improve disease outcomes in mice. These findings uncover a complete IL-17A–CHI3L1–IL-13Rα2–LCN2 signaling network, positioning CHI3L1 as both a mechanistic effector and a promising therapeutic target in MASH-fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathophysiology, Basic Medicine College, China Medical University, Shenyang, China.
- Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China.
- Department of Immunology, Basic Medicine College, China Medical University, Shenyang, China.
- Department of Laboratory Animal Science, China Medical University, Shenyang, China.
- The First Clinical College of China Medical University, Shenyang, China.
- Department of Pathogenic Microbiology, School of Basic Medical Science, China Medical University, Shenyang, China.
ORCID-Profile: Qianqian Zheng, Yanli Cao, Xuefeng Jiang, Xiao Wang, Xiaonan Wang, Tengyu Wang, Xinyu Li, Chen Ding, Xun Sun
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province
- Department of Education of Liaoning Province
- Xingliao Program of Excellence Young Medical Masters Project of Liaoning Provincial Health Commission YLC
- Shenyang Matching Fund for Provincial Youth Science and Technology Talent Projects QQZ
Zitieren
APA
Zheng, Q., Cao, Y., Jiang, X., Wang, X., Wang, X., He, Y., Ma, W., Wu, H., Jiang, Y., Wang, T., Li, X., Ding, C., & Sun, X. (2025). Decoding the CHI3L1/IL-13Rα2 signaling nexus in MASH-fibrosis pathogenesis. Science Advances, 11(50). https://doi.org/10.1126/sciadv.adz3223
Vancouver
Zheng Q, Cao Y, Jiang X, Wang X, Wang X, He Y, et al. Decoding the CHI3L1/IL-13Rα2 signaling nexus in MASH-fibrosis pathogenesis. Science Advances. 2025;11(50). doi:10.1126/sciadv.adz3223
BibTeX
@article{Zheng2025,
author = {Zheng, Qianqian and Cao, Yanli and Jiang, Xuefeng and Wang, Xiao and Wang, Xiaonan and He, Yan and Ma, Wenmeng and Wu, Hao and Jiang, Yuxuan and Wang, Tengyu and Li, Xinyu and Ding, Chen and Sun, Xun},
title = {Decoding the CHI3L1/IL-13Rα2 signaling nexus in MASH-fibrosis pathogenesis},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {50},
doi = {10.1126/sciadv.adz3223}
}
EUVIMED